These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

242 related articles for article (PubMed ID: 22847237)

  • 1. Candida albicans biofilm chip (CaBChip) for high-throughput antifungal drug screening.
    Srinivasan A; Lopez-Ribot JL; Ramasubramanian AK
    J Vis Exp; 2012 Jul; (65):e3845. PubMed ID: 22847237
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Development of a high-throughput Candida albicans biofilm chip.
    Srinivasan A; Uppuluri P; Lopez-Ribot J; Ramasubramanian AK
    PLoS One; 2011 Apr; 6(4):e19036. PubMed ID: 21544190
    [TBL] [Abstract][Full Text] [Related]  

  • 3. High-throughput nano-biofilm microarray for antifungal drug discovery.
    Srinivasan A; Leung KP; Lopez-Ribot JL; Ramasubramanian AK
    mBio; 2013 Jun; 4(4):. PubMed ID: 23800397
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A 96 well microtiter plate-based method for monitoring formation and antifungal susceptibility testing of Candida albicans biofilms.
    Pierce CG; Uppuluri P; Tummala S; Lopez-Ribot JL
    J Vis Exp; 2010 Oct; (44):. PubMed ID: 21048668
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Techniques for antifungal susceptibility testing of Candida albicans biofilms.
    Ramage G; López-Ribot JL
    Methods Mol Med; 2005; 118():71-9. PubMed ID: 15888936
    [TBL] [Abstract][Full Text] [Related]  

  • 6. High-content phenotypic screenings to identify inhibitors of Candida albicans biofilm formation and filamentation.
    Pierce CG; Saville SP; Lopez-Ribot JL
    Pathog Dis; 2014 Apr; 70(3):423-31. PubMed ID: 24623598
    [TBL] [Abstract][Full Text] [Related]  

  • 7. High-throughput screening of a collection of known pharmacologically active small compounds for identification of Candida albicans biofilm inhibitors.
    Siles SA; Srinivasan A; Pierce CG; Lopez-Ribot JL; Ramasubramanian AK
    Antimicrob Agents Chemother; 2013 Aug; 57(8):3681-7. PubMed ID: 23689719
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Thymus vulgaris essential oil and thymol inhibit biofilms and interact synergistically with antifungal drugs against drug resistant strains of Candida albicans and Candida tropicalis.
    Jafri H; Ahmad I
    J Mycol Med; 2020 Apr; 30(1):100911. PubMed ID: 32008964
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Drug susceptibility of matrix-encapsulated Candida albicans nano-biofilms.
    Srinivasan A; Gupta CM; Agrawal CM; Leung KP; Lopez-Ribot JL; Ramasubramanian AK
    Biotechnol Bioeng; 2014 Feb; 111(2):418-24. PubMed ID: 24114441
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Development of Anti-Virulence Approaches for Candidiasis via a Novel Series of Small-Molecule Inhibitors of
    Romo JA; Pierce CG; Chaturvedi AK; Lazzell AL; McHardy SF; Saville SP; Lopez-Ribot JL
    mBio; 2017 Dec; 8(6):. PubMed ID: 29208749
    [No Abstract]   [Full Text] [Related]  

  • 11. A 384-Well Microtiter Plate Model for Candida Biofilm Formation and Its Application to High-Throughput Screening.
    Ajetunmobi OH; Wall G; Bonifacio BV; Montelongo-Jauregui D; Lopez-Ribot JL
    Methods Mol Biol; 2023; 2658():53-64. PubMed ID: 37024695
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Screening the Pathogen Box for Identification of Candida albicans Biofilm Inhibitors.
    Vila T; Lopez-Ribot JL
    Antimicrob Agents Chemother; 2017 Jan; 61(1):. PubMed ID: 27795383
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Utilization of an in vitro biofabricated 3D skin as a pathological model of cutaneous candidiasis.
    Kitisin T; Muangkaew W; Ampawong S; Sukphopetch P
    New Microbiol; 2020 Oct; 43(4):171-179. PubMed ID: 33021319
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A histone deacetylase complex mediates biofilm dispersal and drug resistance in Candida albicans.
    Nobile CJ; Fox EP; Hartooni N; Mitchell KF; Hnisz D; Andes DR; Kuchler K; Johnson AD
    mBio; 2014 Jun; 5(3):e01201-14. PubMed ID: 24917598
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Relevance of antifungal penetration in biofilm-associated resistance of Candida albicans and non-albicans Candida species.
    Singh R; Kumari A; Kaur K; Sethi P; Chakrabarti A
    J Med Microbiol; 2018 Jul; 67(7):922-926. PubMed ID: 29767615
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Novel high-throughput screen against Candida albicans identifies antifungal potentiators and agents effective against biofilms.
    LaFleur MD; Lucumi E; Napper AD; Diamond SL; Lewis K
    J Antimicrob Chemother; 2011 Apr; 66(4):820-6. PubMed ID: 21393183
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Candida species isolated from different body sites and their antifungal susceptibility pattern: Cross-analysis of Candida albicans and Candida glabrata biofilms.
    Cataldi V; Di Campli E; Fazii P; Traini T; Cellini L; Di Giulio M
    Med Mycol; 2017 Aug; 55(6):624-634. PubMed ID: 27915303
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Standardized method for in vitro antifungal susceptibility testing of Candida albicans biofilms.
    Ramage G; Vande Walle K; Wickes BL; López-Ribot JL
    Antimicrob Agents Chemother; 2001 Sep; 45(9):2475-9. PubMed ID: 11502517
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Sensitization of Candida albicans biofilms to various antifungal drugs by cyclosporine A.
    Shinde RB; Chauhan NM; Raut JS; Karuppayil SM
    Ann Clin Microbiol Antimicrob; 2012 Oct; 11():27. PubMed ID: 23035934
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Antifungal activity of amphotericin B and voriconazole against the biofilms and biofilm-dispersed cells of Candida albicans employing a newly developed in vitro pharmacokinetic model.
    El-Azizi M; Farag N; Khardori N
    Ann Clin Microbiol Antimicrob; 2015 Apr; 14():21. PubMed ID: 25885806
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.